Visibility of liquid embolic agents in fluoroscopy: a systematic in vitro study

Background Endovascular embolization using liquid embolic agents (LEAs) is frequently applied for the treatment of intracranial vascular malformations. Appropriate visibility of LEAs during embolization is essential for visual control and to prevent complications. Since LEAs contain different radiop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schmitt, Niclas (VerfasserIn) , Wucherpfennig, Lena (VerfasserIn) , Hohenstatt, Sophia (VerfasserIn) , Weyland, Charlotte S. (VerfasserIn) , Sommer, Christof-Matthias (VerfasserIn) , Bendszus, Martin (VerfasserIn) , Möhlenbruch, Markus Alfred (VerfasserIn) , Vollherbst, Dominik (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2023
In: Journal of neuroInterventional surgery
Year: 2023, Jahrgang: 15, Heft: 6, Pages: 594-599
ISSN:1759-8486
DOI:10.1136/neurintsurg-2022-018958
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1136/neurintsurg-2022-018958
Verlag, kostenfrei, Volltext: https://jnis.bmj.com/content/15/6/594
Volltext
Verfasserangaben:Niclas Schmitt, Lena Wucherpfennig, Sophia Hohenstatt, Charlotte S. Weyland, Christof M. Sommer, Martin Bendszus, Markus A. Möhlenbruch, Dominik F. Vollherbst

MARC

LEADER 00000caa a2200000 c 4500
001 1848818211
003 DE-627
005 20230706204048.0
007 cr uuu---uuuuu
008 230612s2023 xx |||||o 00| ||eng c
024 7 |a 10.1136/neurintsurg-2022-018958  |2 doi 
035 |a (DE-627)1848818211 
035 |a (DE-599)KXP1848818211 
035 |a (OCoLC)1389529779 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmitt, Niclas  |d 1991-  |e VerfasserIn  |0 (DE-588)1179970675  |0 (DE-627)1067581588  |0 (DE-576)51844225X  |4 aut 
245 1 0 |a Visibility of liquid embolic agents in fluoroscopy  |b a systematic in vitro study  |c Niclas Schmitt, Lena Wucherpfennig, Sophia Hohenstatt, Charlotte S. Weyland, Christof M. Sommer, Martin Bendszus, Markus A. Möhlenbruch, Dominik F. Vollherbst 
264 1 |c 2023 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online first 4 May 2022 
500 |a Gesehen am 12.06.2023 
520 |a Background Endovascular embolization using liquid embolic agents (LEAs) is frequently applied for the treatment of intracranial vascular malformations. Appropriate visibility of LEAs during embolization is essential for visual control and to prevent complications. Since LEAs contain different radiopaque components of varying concentrations, our aim was the systematic assessment of the visibility of the most used LEAs in fluoroscopy. - Methods A specifically designed in vitro model, resembling cerebral vessels, was embolized with Onyx 18, Squid 18, Squid 12, PHIL (precipitating hydrophobic injectable liquid) 25%, PHIL LV (low viscosity) and NBCA (n-butyl cyanoacrylate) mixed with iodized oil (n=3 for each LEA), as well as with contrast medium and saline, both serving as a reference. Fluoroscopic image acquisition was performed in accordance with clinical routine settings. Visibility was graded quantitatively (contrast to noise ratio, CNR) and qualitatively (five-point scale). - Results Overall, all LEAs provided at least acceptable visibility in this in vitro model. Onyx and Squid as well as NBCA mixed with iodized oil were best visible at a comparable level and superior to the formulations of PHIL, which did not differ in quantitative and qualitative analyses (eg, Onyx 18 vs PHIL 25% along the 2.0 mm sector: mean CNR±SD: 3.02±0.42 vs 1.92±0.35; mean score±SD: 5.00±0.00 vs 3.75±0.45; p≤0.001, respectively). - Conclusion In this systematic in vitro study, relevant differences in the fluoroscopic visibility of LEAs in neurointerventional embolization procedures were demonstrated, while all investigated LEAs provided acceptable visibility in our in vitro model. 
650 4 |a Angiography 
650 4 |a Arteriovenous Malformation 
650 4 |a Fistula 
650 4 |a Liquid Embolic Material 
650 4 |a Vascular Malformation 
700 1 |a Wucherpfennig, Lena  |d 1992-  |e VerfasserIn  |0 (DE-588)1200972732  |0 (DE-627)1684107172  |4 aut 
700 1 |a Hohenstatt, Sophia  |d 1994-  |e VerfasserIn  |0 (DE-588)1284014207  |0 (DE-627)1839711493  |4 aut 
700 1 |a Weyland, Charlotte S.  |d 1990-  |e VerfasserIn  |0 (DE-588)1208458426  |0 (DE-627)1694725235  |4 aut 
700 1 |a Sommer, Christof-Matthias  |d 1978-  |e VerfasserIn  |0 (DE-588)133929701  |0 (DE-627)558738699  |0 (DE-576)278278035  |4 aut 
700 1 |a Bendszus, Martin  |e VerfasserIn  |0 (DE-588)1032676426  |0 (DE-627)738634131  |0 (DE-576)175567697  |4 aut 
700 1 |a Möhlenbruch, Markus Alfred  |d 1979-  |e VerfasserIn  |0 (DE-588)137693591  |0 (DE-627)594845041  |0 (DE-576)304845655  |4 aut 
700 1 |a Vollherbst, Dominik  |d 1989-  |e VerfasserIn  |0 (DE-588)1071379569  |0 (DE-627)825819024  |0 (DE-576)407878866  |4 aut 
773 0 8 |i Enthalten in  |t Journal of neuroInterventional surgery  |d London : BMJ Journals, 2009  |g 15(2023), 6 vom: Mai, Seite 594-599  |h Online-Ressource  |w (DE-627)605217548  |w (DE-600)2506028-4  |w (DE-576)308906721  |x 1759-8486  |7 nnas  |a Visibility of liquid embolic agents in fluoroscopy a systematic in vitro study 
773 1 8 |g volume:15  |g year:2023  |g number:6  |g month:05  |g pages:594-599  |g extent:6  |a Visibility of liquid embolic agents in fluoroscopy a systematic in vitro study 
856 4 0 |u https://doi.org/10.1136/neurintsurg-2022-018958  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://jnis.bmj.com/content/15/6/594  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230612 
993 |a Article 
994 |a 2023 
998 |g 1071379569  |a Vollherbst, Dominik  |m 1071379569:Vollherbst, Dominik  |d 910000  |d 911100  |d 50000  |e 910000PV1071379569  |e 911100PV1071379569  |e 50000PV1071379569  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 8  |y j 
998 |g 137693591  |a Möhlenbruch, Markus Alfred  |m 137693591:Möhlenbruch, Markus Alfred  |d 910000  |d 911100  |d 50000  |e 910000PM137693591  |e 911100PM137693591  |e 50000PM137693591  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 7 
998 |g 1032676426  |a Bendszus, Martin  |m 1032676426:Bendszus, Martin  |d 910000  |d 911100  |e 910000PB1032676426  |e 911100PB1032676426  |k 0/910000/  |k 1/910000/911100/  |p 6 
998 |g 133929701  |a Sommer, Christof-Matthias  |m 133929701:Sommer, Christof-Matthias  |d 910000  |d 911400  |d 50000  |e 910000PS133929701  |e 911400PS133929701  |e 50000PS133929701  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 5 
998 |g 1208458426  |a Weyland, Charlotte S.  |m 1208458426:Weyland, Charlotte S.  |d 910000  |d 911100  |e 910000PW1208458426  |e 911100PW1208458426  |k 0/910000/  |k 1/910000/911100/  |p 4 
998 |g 1284014207  |a Hohenstatt, Sophia  |m 1284014207:Hohenstatt, Sophia  |d 910000  |d 911100  |e 910000PH1284014207  |e 911100PH1284014207  |k 0/910000/  |k 1/910000/911100/  |p 3 
998 |g 1200972732  |a Wucherpfennig, Lena  |m 1200972732:Wucherpfennig, Lena  |d 910000  |d 911400  |e 910000PW1200972732  |e 911400PW1200972732  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 1179970675  |a Schmitt, Niclas  |m 1179970675:Schmitt, Niclas  |d 910000  |d 911100  |e 910000PS1179970675  |e 911100PS1179970675  |k 0/910000/  |k 1/910000/911100/  |p 1  |x j 
999 |a KXP-PPN1848818211  |e 4331489396 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1848818211"],"doi":["10.1136/neurintsurg-2022-018958"]},"language":["eng"],"name":{"displayForm":["Niclas Schmitt, Lena Wucherpfennig, Sophia Hohenstatt, Charlotte S. Weyland, Christof M. Sommer, Martin Bendszus, Markus A. Möhlenbruch, Dominik F. Vollherbst"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1848818211","physDesc":[{"extent":"6 S."}],"title":[{"subtitle":"a systematic in vitro study","title_sort":"Visibility of liquid embolic agents in fluoroscopy","title":"Visibility of liquid embolic agents in fluoroscopy"}],"person":[{"display":"Schmitt, Niclas","role":"aut","given":"Niclas","family":"Schmitt"},{"role":"aut","display":"Wucherpfennig, Lena","given":"Lena","family":"Wucherpfennig"},{"family":"Hohenstatt","given":"Sophia","display":"Hohenstatt, Sophia","role":"aut"},{"role":"aut","display":"Weyland, Charlotte S.","given":"Charlotte S.","family":"Weyland"},{"given":"Christof-Matthias","family":"Sommer","display":"Sommer, Christof-Matthias","role":"aut"},{"display":"Bendszus, Martin","role":"aut","given":"Martin","family":"Bendszus"},{"role":"aut","display":"Möhlenbruch, Markus Alfred","given":"Markus Alfred","family":"Möhlenbruch"},{"given":"Dominik","family":"Vollherbst","role":"aut","display":"Vollherbst, Dominik"}],"relHost":[{"title":[{"subtitle":"JNIS ; the journal of the Society of NeuroInterventional Surgery","title":"Journal of neuroInterventional surgery","title_sort":"Journal of neuroInterventional surgery"}],"part":{"pages":"594-599","text":"15(2023), 6 vom: Mai, Seite 594-599","issue":"6","volume":"15","year":"2023","extent":"6"},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Visibility of liquid embolic agents in fluoroscopy a systematic in vitro studyJournal of neuroInterventional surgery","titleAlt":[{"title":"JNIS"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 03.01.11"],"origin":[{"publisherPlace":"London","dateIssuedKey":"2009","dateIssuedDisp":"2009-","publisher":"BMJ Journals"}],"pubHistory":["1.2009 -"],"id":{"zdb":["2506028-4"],"eki":["605217548"],"issn":["1759-8486"]},"recId":"605217548"}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"2023"}],"note":["Published online first 4 May 2022","Gesehen am 12.06.2023"]} 
SRT |a SCHMITTNICVISIBILITY2023